Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Transplantation

Thrombalexins protect renal allografts

Nature Reviews Nephrology volume 12, page 510 (2016)Cite this article

Subjects

Researchers have used a membrane-localizing technology to generate a novel class of thrombin inhibitors, named thrombalexins (TLNs), that bind to cell surfaces and could potentially be used to prevent acute antibody-mediated thrombosis in donor organs. In a rat renal allograft model of hyperacute antibody-mediated rejection, perfusion of donor kidneys with TLN-1 before transplantation substantially reduced intragraft thrombosis and increased graft survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Karegli, J. et al. Thrombalexins: cell-localized inhibition of thrombin and its effects in a model of high-risk renal transplantation. Am. J. Transplant. http://dx.doi.org/10.1111/ajt.13951 (2016)

Download references

Authors
  1. Ellen Carney
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carney, E. Thrombalexins protect renal allografts. Nat Rev Nephrol 12, 510 (2016). https://doi.org/10.1038/nrneph.2016.117

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrneph.2016.117

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing